714X is a non toxic innovative health product focussed on the immune system.

Because one of the most important anatomic features of the immune system is the lymphatic system, 714X was purposely designed to be introduced directly into the lymphatic circulation.

This unique mode of application confirms the innovative character of the product altogether different than any other health products on the market.  Most health products are either metabolized by the digestive system or injected in the blood circulation.

For someone who is newly introduced to the 714X, what does introducing a product directly into the lymphatic circulation mean?

Let’s get a closer look at the lymphatic system.

Nature has provided the human body with a lymphatic circulation consisting of two independent networks.  The small and the large lymphatic circulations.  In order for the product to reach the two lymphatic circulations two different methods of administration must be used.

The diagram below clearly illustrates the overall lymphatic system with its two parallel lymphatic circulations.  Both lymphatic circulations drain into the blood circulation but they never meet.  They are totally independent.

The small lymphatic circulation (in blue) drains the upper part of the right side of the body (right arm, head, and neck). The large lymphatic circulation (in green) drains the lower part of the body as well as the upper left side (2 legs, left arm, head and neck).

714X has a unique mode of administration.  It is designed to be introduced directly into the lymphatic circulation, respecting nature’s anatomic specificity.

Consequently, to introduce 714X in the body, two methods are necessary due to the anatomical requirements of the two lymphatic circulations:

1. Basic method as the standard protocol: to reach the large lymphatic circulation in the most practical and efficient way, 714X is introduced as an injection to be given in the right groin area.
   
   714X to be injected by way of perinodular injections differs in format and concentration from the product used for inhalation (multidose 6.5 ml vials).



                                     

2. The secondary method is the adjuvant protocol
   
   To reach the small lymphatic circulation in the most practical and efficient way, 714X is introduced by inhalation with the support of a device called a nebuliser.
   714X to be inhaled differs in format and concentration from the product to be injected (a unidose 1 ml ampoule).